Accounts Receivables - Carna Biosciences Inc (TSE:4572) - Alpha Spread

Watchlist Manager

Watchlist

Price: 436 JPY 0.23%

Updated:

Carna Biosciences Inc
Accounts Receivables

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

|

Adjust for Inflation

Carna Biosciences Inc
Accounts Receivables Peer Comparison

2309

S

2395

2370

4880

2183

Company		Accounts Receivables	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Carna Biosciences Inc TSE:4572	Accounts Receivables ¥788.2m	CAGR 3-Years 83%	CAGR 5-Years 55%	CAGR 10-Years 21%
	CMIC Holdings Co Ltd TSE:2309	Accounts Receivables ¥16.9B	CAGR 3-Years 7%	CAGR 5-Years 5%	CAGR 10-Years 8%
S	Shin Nippon Biomedical Laboratories Ltd TSE:2395	Accounts Receivables ¥5.7B	CAGR 3-Years 25%	CAGR 5-Years 24%	CAGR 10-Years 8%
	Medinet Co Ltd TSE:2370	Accounts Receivables ¥204.5m	CAGR 3-Years 14%	CAGR 5-Years -5%	CAGR 10-Years -4%
	CellSource Co Ltd TSE:4880	Accounts Receivables ¥361.5m	CAGR 3-Years 17%	CAGR 5-Years 21%	CAGR 10-Years N/A
	Linical Co Ltd TSE:2183	Accounts Receivables ¥3.2B	CAGR 3-Years 12%	CAGR 5-Years 12%	CAGR 10-Years 17%

See Also

Based on the financial report for Dec 31, 2023, Carna Biosciences Inc's Accounts Receivables amounts to 788.2m JPY.

Over the last year, the Accounts Receivables growth was 332%. The average annual Accounts Receivables growth rates for Carna Biosciences Inc have been 83% over the past three years , 55% over the past five years , and 21% over the past ten years .

Join more than 138,800+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.